Literature DB >> 18374637

Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.

G Tsiolakidou1, I E Koutroubakis, M Tzardi, E A Kouroumalis.   

Abstract

BACKGROUND: Angiogenesis has been suggested as an integral part of inflammatory bowel disease pathology. Vascular endothelial growth factor has long been considered to play a central, specific role in angiogenesis. Endothelial junction adhesion molecules, such as CD146, have recently been suggested to play a potent role in angiogenesis. CD34 is expressed on vascular endothelium, and it has been reported to be upregulated on endothelium in IBD. We investigated the expression of tissue vascular endothelial growth factor, CD34 and CD146 in the inflamed mucosa of patients with active inflammatory bowel disease compared with no inflamed mucosa of healthy controls.
METHODS: Forty-two IBD patients [23 ulcerative colitis, 19 Crohn's disease] and ten healthy controls were included in the study. In colonoscopically obtained biopsies, CD34, CD146 and vascular endothelial growth factor expression were evaluated by immunohistochemistry.
RESULTS: Vascular endothelial growth factor was detected in the mucosa of all groups, and its expression was significantly higher in both Crohn's disease and ulcerative colitis compared with controls (p<0.05). Immunohistochemical staining for CD146 in the inflamed mucosa was significantly higher in both Crohn's disease and ulcerative colitis compared with controls (p=0.002). A trend of higher CD34 expression in Crohn's disease and ulcerative colitis compared with controls was also found, but the difference among the three groups was not statistically significant (p=0.09).
CONCLUSIONS: Inflamed mucosa of patients with active Crohn's disease and ulcerative colitis showed a markedly enhanced expression of VEGF and CD146, than normal mucosa of controls, indicating a possible role of angiogenesis in the pathogenesis of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374637     DOI: 10.1016/j.dld.2008.02.010

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  19 in total

1.  Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis.

Authors:  Jun Huang; Ciarán P Kelly; Kyriaki Bakirtzi; Javier A Villafuerte Gálvez; Dena Lyras; Steven J Mileto; Sarah Larcombe; Hua Xu; Xiaotong Yang; Kelsey S Shields; Weishu Zhu; Yi Zhang; Jeffrey D Goldsmith; Ishan J Patel; Joshua Hansen; Meijin Huang; Seppo Yla-Herttuala; Alan C Moss; Daniel Paredes-Sabja; Charalabos Pothoulakis; Yatrik M Shah; Jianping Wang; Xinhua Chen
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

2.  VEGF₁₆₄ isoform specific regulation of T-cell-dependent experimental colitis in mice.

Authors:  John H Chidlow; John D Glawe; Christopher B Pattillo; Sibile Pardue; Songlin Zhang; Christopher G Kevil
Journal:  Inflamm Bowel Dis       Date:  2010-11-09       Impact factor: 5.325

Review 3.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

4.  Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway.

Authors:  Sang Hoon Rhee; Elise L Ma; Yunna Lee; Yvette Taché; Charalabos Pothoulakis; Eunok Im
Journal:  J Biol Chem       Date:  2015-09-08       Impact factor: 5.157

Review 5.  Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

Authors:  Franco Scaldaferri; Carmen Correale; Antonio Gasbarrini; Silvio Danese
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

6.  Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.

Authors:  Wei Li; Liangyi Liu; Aurelie Gomez; Jilu Zhang; Abdulraouf Ramadan; Qing Zhang; Sung W Choi; Peng Zhang; Joel K Greenson; Chen Liu; Di Jiang; Elizabeth Virts; Stephanie L Kelich; Hong Wei Chu; Ryan Flynn; Bruce R Blazar; Helmut Hanenberg; Samir Hanash; Sophie Paczesny
Journal:  JCI Insight       Date:  2016-05-05

Review 7.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

8.  MicroRNA 329 suppresses angiogenesis by targeting CD146.

Authors:  Ping Wang; Yongting Luo; Hongxia Duan; Shu Xing; Jianlin Zhang; Di Lu; Jing Feng; Dongling Yang; Lina Song; Xiyun Yan
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

9.  Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis.

Authors:  C E Vitor; C P Figueiredo; D B Hara; A F Bento; T L Mazzuco; J B Calixto
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

10.  Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats.

Authors:  Celso L R Belmiro; Morgana T L Castelo-Branco; Leandra M C Melim; Alberto Schanaider; Celeste Elia; Kalil Madi; Mauro S G Pavão; Heitor S P de Souza
Journal:  J Biol Chem       Date:  2009-03-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.